VIKAS KUNDRA to Mice, Nude
This is a "connection" page, showing publications VIKAS KUNDRA has written about Mice, Nude.
Connection Strength
0.961
-
In vivo magnetic resonance imaging of orthotopic prostate cancer. Biotechniques. 2020 07; 69(1):395-403.
Score: 0.107
-
Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer. Sci Rep. 2019 04 15; 9(1):6100.
Score: 0.100
-
In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model. Radiology. 2017 12; 285(3):830-838.
Score: 0.089
-
Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One. 2015; 10(6):e0131095.
Score: 0.077
-
Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging. 2013 Oct; 12(7):1-10.
Score: 0.068
-
Visualizing the prostate gland by MR imaging in young and old mice. PLoS One. 2013; 8(3):e55746.
Score: 0.065
-
SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model. Hum Gene Ther. 2011 Jan; 22(1):55-64.
Score: 0.056
-
In vivo functional and anatomic imaging for assessment of in vivo gene transfer. Radiology. 2009 Sep; 252(3):763-71.
Score: 0.051
-
Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer. J Magn Reson Imaging. 2008 Jan; 27(1):57-62.
Score: 0.046
-
Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging. 2007 Nov-Dec; 6(6):427-37.
Score: 0.045
-
Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology. 2005 Jun; 235(3):950-8.
Score: 0.038
-
Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med. 2002 Mar; 43(3):406-12.
Score: 0.031
-
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance. Cell Rep. 2021 08 17; 36(7):109549.
Score: 0.029
-
Virus-Mimicking Nanoparticles for Targeted Near Infrared Fluorescence Imaging of Intraperitoneal Ovarian Tumors in Mice. Ann Biomed Eng. 2021 Feb; 49(2):548-559.
Score: 0.027
-
Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage. Mol Pharm. 2019 02 04; 16(2):808-815.
Score: 0.025
-
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther. 2011 Dec; 10(12):2350-62.
Score: 0.015
-
Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010 Aug 09; 18(2):185-97.
Score: 0.014
-
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
Score: 0.013
-
Pharmacodynamic markers of perifosine efficacy. Clin Cancer Res. 2007 Dec 15; 13(24):7421-31.
Score: 0.011
-
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res. 2007 Oct 01; 67(19):9337-45.
Score: 0.011
-
Feasibility of multiple-mouse dynamic contrast-enhanced MRI. Magn Reson Med. 2007 Sep; 58(3):610-5.
Score: 0.011
-
Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia. 2007 Jun; 9(6):479-86.
Score: 0.011
-
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res. 2006 Oct 01; 66(19):9682-90.
Score: 0.010
-
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006 Aug; 12(8):939-44.
Score: 0.010